Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 33 (2012), Issue 2, Pages 69-76
http://dx.doi.org/10.3233/DMA-2012-0906

Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report

Joanna Sulicka,1,4 Andrzej Surdacki,2,4 Magdalena Strach,1,4 Aleksander Kwater,1,4 Barbara Gryglewska,1,4 Magdalena Ćwiklińska,3,5 Walentyna Balwierz,3,5 and Tomasz K. Grodzicki1,4

1Department of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University, Cracow, Poland
22nd Department of Cardiology, Faculty of Medicine, Jagiellonian University, Cracow, Poland
3Department of Pediatric Oncology and Hematology, Polish-American Institute of Pediatrics, Faculty of Medicine, Jagiellonian University, Cracow, Poland
4University Hospital, Cracow, Poland
5University Children's Hospital, Cracow, Poland

Received 11 July 2012; Accepted 11 July 2012

Copyright © 2012 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Joanna Sulicka, Andrzej Surdacki, Magdalena Strach, et al., “Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report,” Disease Markers, vol. 33, no. 2, pp. 69-76, 2012. doi:10.3233/DMA-2012-0906